Last Updated:
The Afib detection is approved by the FDA and EU regulators
Ultrahuman is an India-based company that offers its smart ring in the market and is bringing this advanced health tech to the segment.
Smart ring is slowly getting into prominence now that Samsung has entered the space but Ultrahuman is sort of a veteran in the category which is now looking to advance its tech with more health features on its smart ring called Ring Air. The India-based wearable startup has got the approvals from the FDA to offer Afib or atrial fibrillation detection, similar to what Apple Watch has offered for a few years now.
The advanced health feature is linked to your heart and wearing a smart ring means the detection works in a different way to your smartwatches. The company has also introduced its own app store which caters to myriad health and fitness tools that can be integrated to its smart wearable rings by third-party developers.
Ultrahuman Ring Air Afib Detection – How It Works
Ultrahuman is using tech called FibriCheck which is essentially using a scientific process by applying light to the skin and monitoring the blood volume that is being pumped by the heart through the body. It also claims to be the first to bring Afib detection to a smart ring, which is no small feat even for a fledgling category.
This tech has got the FDA approvals along with the nod from the European medicine device regulators which is a big win for the company and its push for smart rings in the market. Having said that, Ultrahuman is going to charge the users a monthly subscription fee of $4.90 (Rs 400 approx) to get the Afib benefits running through their Ring Air device.
Ultrahuman is going to bring the Afib feature to countries like the EU, Saudi Arabia, the UAE and the UK among others for now, with plans to offer in the US and India also mooted in the foreseeable future.
Ultrahuman says the tests done on the Afib are quite accurate but because of the seriousness of this feature, it is treading carefully as to how and who can access the feature, and only when it gets the regulatory approvals to push it out in the market.
